CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer

DOI: 10.1080/2162402X.2016.1249558

Keywords: Adoptive cell therapy, checkpoint blockade, CRISPR, EBV-associated gastric cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text